RNSG 1538 - Female Reproductive Medications. Questions and Answers.

RNSG 1538 - Female Reproductive Medications. Questions and Answers. A patient with preeclampsia is receiving IV magnesium sulfate. Which finding should the nurse report to the provider? Respirations 12/minute 2+ pedal edema 2+ deep tendon reflexes 24 ml/hr urinary output. Urine output of less than 15 to 30 ml/hr is associated with magnesium sulfate toxicity and should be reported to the provider. Which nursing interventions are appropriate for a patient who has been started on Oxytocin (Pitocin) to stimulate uterine contractions? Select All That Apply No answer text provided. Provide continuous monitoring of vital signs Vital signs are monitored to assess for hypertension, an adverse affect of oxytocin. Monitor for headache, nausea, vomiting, and increasing blood pressure. Monitor FHR continuously Monitor fetal heart rate and rhythm and report signs of fetal distress. Stop the infusion for serious alterations in fetal heart rate or rhythm. Use an infusion pump for medication administration. Use an infusion pump to administer IV oxytocin . Gradually increase rate per prescribed parameters. Continuously monitor blood pressure/pulse. Carefully monitor the uterine contractions and fetal heart rate and rhythm. Increase medication infusion rapidly. Stop infusion if uterine contractions occur every 4 minutes and last 45 seconds.